New chemo combo before surgery aims to stop prostate cancer spread

NCT ID NCT03258320

Recruiting now Disease control Sponsor: Shanghai Jiao Tong University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jan 07, 2026 · Last updated May 16, 2026 · Updated 19 times

Summary

This study tests giving chemotherapy before surgery to men with high-risk prostate cancer. The goal is to see if this approach helps keep the cancer from coming back for at least 5 years. About 300 men aged 40-75 with early-stage but high-risk prostate cancer will receive one of four chemo drugs, then have surgery. The study is currently recruiting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Qilu Hospital of Shandong University
RECRUITING

Qingdao, Shandong, 266035, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Zhongshan Hospital
RECRUITING

Shanghai, 200032, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER PATIENTS